Tumor cell-tumor endothelial cell adhesion mediated by alphavbeta3 and alphavbeta5 molecules / 中华肿瘤杂志
Ji-Xiao NIU; Wen-Jian ZHANG; Li-Ya YE; Lian-Qiu WU; Zhi-Hua YANG; Guang-Jin ZHU; Jin-Ning LOU.
Chinese Journal of Oncology
; (12): 165-169, 2008.
Artículo
en Zh
| WPRIM | ID: wpr-348141
<p><b>OBJECTIVE</b>To investigate the role of adhesion molecules alphavbeta3 and alphavbeta5 and their ligands Del-1 and L1 in the tumor-endothelial cell adhesion in vitro.</p><p><b>METHODS</b>The expression of alphavbeta3, alphavbeta5 and ICAM-1 in liver sinusoidal endothelial cells (LSEC) and liver cancer endothelial cells (T3A) cultured under normoxia or hypoxia were analyzed by RT-PCR and fluorescent activated cell sorter (FACS). The expression of Del-1 and L1 in six tumor cell lines under normoxia or hypoxia were analyzed by RT-PCR and Western blot, respectively. The adhesion of dye-labeled tumor cells and endothelial LSEC and T3A cells was measured by a fluorescence plate reader after their culture.</p><p><b>RESULTS</b>The expression of alphavbeta3 and alphavbeta5 were higher in T3A cells than that in LSEC cells, and were upregulated under hypoxia, while the expression of ICAM-1 was lower in T3A cells than that in LSEC cells, and was upregulated under hypoxia only in LSEC. The expression of Del-1 and L1 molecules were obviously different in various tumor cell lines and were differentially regulated under hypoxia. The adhesion of tumor cells with Del-1 or L1 expression was higher in T3A cells than that in LSEC cells, and was significantly increased under hypoxia condition. Furthermore, the adhesion of tumor cells to T3A could be inhibited by antibodies against alphavbeta3 and alphavbeta5, or SiRNAs for beta3 and beta5.</p><p><b>CONCLUSION</b>alphavbeta3 and alphavbeta5 and their ligands Del-1 and L1 may play an important role in tumor cell migration.</p>
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados